{"id":"https://openalex.org/W2530254792","doi":"https://doi.org/10.1182/blood.v110.11.2332.2332","title":"Front-Line Treatment of Low-Grade Non-Follicular Non-Hodgkin Lymphoma (Final Report of Gisl LL02 Trial).","display_name":"Front-Line Treatment of Low-Grade Non-Follicular Non-Hodgkin Lymphoma (Final Report of Gisl LL02 Trial).","publication_year":2007,"publication_date":"2007-11-16","ids":{"openalex":"https://openalex.org/W2530254792","doi":"https://doi.org/10.1182/blood.v110.11.2332.2332","mag":"2530254792"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v110.11.2332.2332","doi":"https://doi.org/10.1182/blood.v110.11.2332.2332","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.2332.2332","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112449676","display_name":"Maria Cecilia Goldaniga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Goldaniga","raw_affiliation_strings":["UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy","institution_ids":["https://openalex.org/I2803066834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066201212","display_name":"Francesco Merli","orcid":"https://orcid.org/0000-0002-0979-7883","observed_orcids":["https://orcid.org/0000-0002-0979-7883"]},"institutions":[{"id":"https://openalex.org/I4210102151","display_name":"Santa Maria Nuova Hospital","ror":"https://ror.org/01cyv3m84","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210102151"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Merli","raw_affiliation_strings":["Servizio di Ematologia, Arcispedale S. Maria Nuova, Reggio Emilia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servizio di Ematologia, Arcispedale S. Maria Nuova, Reggio Emilia, Italy","institution_ids":["https://openalex.org/I4210102151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049017377","display_name":"Caterina Cecilia Stelitano","orcid":"https://orcid.org/0000-0002-1520-2970","observed_orcids":["https://orcid.org/0000-0002-1520-2970"]},"institutions":[{"id":"https://openalex.org/I4210098397","display_name":"Azienda ospedaliera \"Bianchi-Melacrino-Morelli\"","ror":"https://ror.org/00z28d984","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210098397"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Caterina Stelitano","raw_affiliation_strings":["Dipartimento di Ematologia, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Ematologia, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy","institution_ids":["https://openalex.org/I4210098397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020113695","display_name":"Vincenzo Callea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098397","display_name":"Azienda ospedaliera \"Bianchi-Melacrino-Morelli\"","ror":"https://ror.org/00z28d984","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210098397"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Vincenzo Callea","raw_affiliation_strings":["Dipartimento di Ematologia, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Ematologia, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy","institution_ids":["https://openalex.org/I4210098397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046680192","display_name":"Fiorella Ilariucci","orcid":"https://orcid.org/0000-0002-4279-3358","observed_orcids":["https://orcid.org/0000-0002-4279-3358"]},"institutions":[{"id":"https://openalex.org/I4210102151","display_name":"Santa Maria Nuova Hospital","ror":"https://ror.org/01cyv3m84","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210102151"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fiorella Ilariucci","raw_affiliation_strings":["Servizio di Ematologia, Arcispedale S. Maria Nuova, Reggio Emilia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servizio di Ematologia, Arcispedale S. Maria Nuova, Reggio Emilia, Italy","institution_ids":["https://openalex.org/I4210102151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111636901","display_name":"Mario Russo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Russo","raw_affiliation_strings":["UO Ematologia, PO San Vincenzo, Taormina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UO Ematologia, PO San Vincenzo, Taormina, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109353289","display_name":"Patrizio Mazza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrizio Mazza","raw_affiliation_strings":["UO Ematologia, AO SS Annunziata, Taranto, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UO Ematologia, AO SS Annunziata, Taranto, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016803459","display_name":"Stefano Luminari","orcid":"https://orcid.org/0000-0001-8446-2285","observed_orcids":["https://orcid.org/0000-0001-8446-2285"]},"institutions":[{"id":"https://openalex.org/I122346577","display_name":"University of Modena and Reggio Emilia","ror":"https://ror.org/02d4c4y02","country_code":"IT","type":"education","lineage":["https://openalex.org/I122346577"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Luminari","raw_affiliation_strings":["Dipartimento di Oncologia e Ematologia, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Oncologia e Ematologia, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy","institution_ids":["https://openalex.org/I122346577"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005074422","display_name":"Francesca Gaia Rossi","orcid":"https://orcid.org/0000-0003-1428-1838","observed_orcids":["https://orcid.org/0000-0003-1428-1838"]},"institutions":[{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Rossi","raw_affiliation_strings":["UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy","institution_ids":["https://openalex.org/I2803066834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038901412","display_name":"Maura Brugiatelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166183","display_name":"Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte","ror":"https://ror.org/05b5q0t82","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210166183"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maura Brugiatelli","raw_affiliation_strings":["Divisione di Ematologia, Azienda Ospedaliera Papardo, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Divisione di Ematologia, Azienda Ospedaliera Papardo, Messina, Italy","institution_ids":["https://openalex.org/I4210166183"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031216906","display_name":"Dimitri Luisi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dimitri Luisi","raw_affiliation_strings":["Dipartimento di Ematologia ed Oncologia, Presidio Ospedaliero, Pescara, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Ematologia ed Oncologia, Presidio Ospedaliero, Pescara, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049641308","display_name":"Barbara Olivero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Barbara Olivero","raw_affiliation_strings":["UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy","institution_ids":["https://openalex.org/I2803066834"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Giorgio Lambertenghi Deliliers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giorgio Lambertenghi Deliliers","raw_affiliation_strings":["UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy","institution_ids":["https://openalex.org/I2803066834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114375408","display_name":"Massimo Federico","orcid":"https://orcid.org/0000-0002-5074-3262","observed_orcids":["https://orcid.org/0000-0002-5074-3262"]},"institutions":[{"id":"https://openalex.org/I122346577","display_name":"University of Modena and Reggio Emilia","ror":"https://ror.org/02d4c4y02","country_code":"IT","type":"education","lineage":["https://openalex.org/I122346577"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimo Federico","raw_affiliation_strings":["Dipartimento di Oncologia e Ematologia, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Oncologia e Ematologia, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy","institution_ids":["https://openalex.org/I122346577"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071379560","display_name":"Luca Baldini","orcid":"https://orcid.org/0000-0003-2964-9981","observed_orcids":["https://orcid.org/0000-0003-2964-9981"]},"institutions":[{"id":"https://openalex.org/I2803066834","display_name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","ror":"https://ror.org/016zn0y21","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I2803066834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Baldini","raw_affiliation_strings":["UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UO Ematologia 1, Ospedale Maggiore Policlinico MaRe, Milan, Italy","institution_ids":["https://openalex.org/I2803066834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2885,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.6789011,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"110","issue":"11","first_page":"2332","last_page":"2332"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/indolent-non-hodgkin-lymphoma","display_name":"indolent non-Hodgkin lymphoma","score":0.9020000100135803},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8659999966621399},{"id":"https://openalex.org/keywords/thymidylate-synthase-inhibitors","display_name":"thymidylate synthase inhibitors","score":0.6650000214576721},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.5899999737739563},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6880000233650208},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9340000152587891},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.7919999957084656},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8827916979789734},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6580948233604431},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6443642973899841},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5690754652023315},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4744100272655487},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4741325378417969},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4523807168006897},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.42772069573402405},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.423572838306427},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.40372800827026367},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3014640808105469}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v110.11.2332.2332","doi":"https://doi.org/10.1182/blood.v110.11.2332.2332","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.2332.2332","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2076652869","https://openalex.org/W3125006501","https://openalex.org/W2058260031","https://openalex.org/W7019108756","https://openalex.org/W2132382025","https://openalex.org/W2590555887","https://openalex.org/W4248242205","https://openalex.org/W2357852444","https://openalex.org/W2557744148","https://openalex.org/W2560769538"],"abstract_inverted_index":{"Abstract":[0],"Indolent":[1],"Non-follicular":[2],"non-Hodgkin":[3],"Lymphoma":[4],"(NFo-NHL)":[5],"is":[6,283,335],"a":[7,32,101,148,170,247,273,284,345],"group":[8],"of":[9,48,55,103,150,156,172,178,250,266,275,304,329],"relatively":[10],"frequent":[11],"lymphoproliferative":[12],"diseases,":[13],"nevertheless":[14],"extended":[15],"clinical":[16],"and":[17,46,65,73,176,189,206,210,220,222,230,234,261,299],"prognostic":[18],"studies":[19],"are":[20],"still":[21],"lacking.":[22],"In":[23],"2002":[24,64],"the":[25,40,44,52,128,136,161,164,213,223,238,241,280,326,340],"Gruppo":[26],"Italiano":[27],"Studio":[28],"Linfomi":[29],"(GISL)":[30],"initiated":[31],"LL02":[33],"prospective":[34],"multicenter":[35],"phase":[36],"II":[37],"trial,":[38],"with":[39,100,147,169,203,246,294,317,321],"aim":[41],"to":[42,311,343],"evaluate":[43],"efficacy":[45],"safety":[47],"FC":[49,281,305,333],"combination":[50],"in":[51,85,92,185,191,315,337,349],"first-line":[53],"therapy":[54],"NFo-NHL":[56,84],"patients":[57,70,130,140,183,267],"younger":[58],"than":[59],"70":[60],"years.":[61],"Between":[62],"July":[63],"September":[66],"2006,":[67],"58":[68],"adult":[69],"(35":[71],"males":[72],"23":[74],"females,":[75],"median":[76,196],"age":[77],"64":[78],"yrs,":[79],"range":[80],"40\u201375)":[81],"affected":[82],"by":[83],"active":[86],"disease":[87,187,193],"phase,":[88],"were":[89,98,184],"consecutively":[90],"enrolled":[91],"12":[93,209,233],"GISL":[94],"Hematological":[95],"Centres.":[96],"Patients":[97],"treated":[99],"dose":[102],"25":[104],"mg/mq":[105,109],"Fludarabine":[106],"plus":[107,154,332],"250":[108],"Cyclophosphamide":[110],"administred":[111],"intravenously":[112],"daily":[113],"for":[114,124,287],"3":[115],"days;":[116],"each":[117],"cycle":[118],"was":[119,167,200,218,228,244],"repeated":[120],"every":[121],"28":[122],"days":[123],"6":[125],"courses.":[126],"During":[127],"treatment":[129],"received":[131],"oral":[132],"thrimethoprim-sulphametoxazole":[133],"prophylaxis.":[134],"After":[135],"intermediate":[137],"evaluation,":[138],"48/58":[139],"(82.8%)":[141],"had":[142,268],"an":[143,204,269,295],"objective":[144],"response":[145],"(ORR)":[146],"20.7%":[149],"complete":[151],"remission":[152,158],"(CR)":[153],"62.1%":[155],"partial":[157],"(PR);":[159],"at":[160,208,232],"final":[162],"evaluation":[163],"ORR":[165],"percentage":[166],"84.5%":[168],"41.4%":[171],"CR":[173,298],"(24":[174],"pts)":[175],"43.1%":[177],"PR":[179],"(25":[180],"pts);":[181],"three":[182],"progressive":[186],"(5.2%)":[188],"one":[190],"stable":[192],"(1.7%).":[194],"The":[195,264,301],"overall":[197],"survival":[198,216,226],"(OS)":[199],"not":[201,309],"reached":[202],"88%":[205],"84%":[207],"24":[211,235],"months;":[212],"progression":[214],"free":[215,225],"(PFS)":[217],"89%":[219],"77%":[221],"event":[224],"(EFS)":[227],"81%":[229],"66%":[231],"months":[236],"respectively.About":[237],"toxicity":[239,243],"profile,":[240],"major":[242],"hematological":[245],"18%":[248],"cases":[249],"WHO":[251,276],"grade":[252,277],"III":[253],"or":[254,320],"IV":[255],"anemia,":[256],"40%":[257],"leucopenia,":[258],"33%":[259],"neutropenia":[260],"10%":[262],"piastrinopenia.":[263],"12%":[265],"infective":[270],"episode":[271],"wich":[272],"7.7%":[274],"III\u2013IV.In":[278],"conclusion":[279],"chemotherapy":[282],"useful":[285],"chance":[286],"advanced":[288],"untreated":[289],"non":[290],"follicular":[291],"low-grade":[292],"NHL,":[293],"optimal":[296],"ORR,":[297],"PFS.":[300],"crucial":[302],"point":[303],"remains":[306],"OS,":[307],"that":[308],"seems":[310],"be":[312],"significantly":[313],"improved":[314],"comparison":[316],"fludarabine":[318],"alone":[319],"standard":[322],"therapy,":[323],"even":[324],"though":[325],"better":[327],"quality":[328],"responses;":[330],"Rituximab":[331],"association":[334],"growing":[336],"literature":[338],"as":[339],"probably":[341],"key":[342],"find":[344],"real":[346],"improvement":[347],"also":[348],"this":[350],"aspect.":[351]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-10-21T00:00:00"}